NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
Anthos Therapeutics, Inc.
University of Texas Southwestern Medical Center
Johns Hopkins University
M.D. Anderson Cancer Center
Cardiff University
University of Alabama at Birmingham
University Medical Center Groningen